Date: 04/11/06
Length: 00:17:02
Size: 7.9MB
Thought Leader: Dr. Peter Hug, Executive VP, Pharma Partnering — F. Hoffman-La Roche Ltd.
Find out what pharmaceutical giant Roche looks for in partnering opportunities, as well as views on personalized medicine and venture capitalists...
Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Tuesday, June 13, 2006
How Consumer Web Traffic May Impact Revenue for Top Selling Drugs
Date: 03/27/06
Length: 00:18:15
Size: 8.5MB
Thought Leader: Daniel Limbach, Managing Editor — PharmaVOICE VIEW magazine
Do the top selling drugs have the highest traffic Websites? Is there a connection? We study this premise using recent traffic data and drug sales figures. You might be surprised what we discovered...
Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Length: 00:18:15
Size: 8.5MB
Thought Leader: Daniel Limbach, Managing Editor — PharmaVOICE VIEW magazine
Do the top selling drugs have the highest traffic Websites? Is there a connection? We study this premise using recent traffic data and drug sales figures. You might be surprised what we discovered...
Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Evolution of a Biopharmaceutical Company: Nektar Therapeutics
Date: 04/11/06
Length: 00:11:48
Size: 5.5MB
Thought Leader: Hoyoung Huh, M.D. Ph.D., Senior VP, Business Development — Nektar Therapeutics
Nektar has crossed the chasm from a drug-delivery-technology company to a product-development company. Dr. Huh describes how they made the transition, and what to look for from them in the future.
Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Length: 00:11:48
Size: 5.5MB
Thought Leader: Hoyoung Huh, M.D. Ph.D., Senior VP, Business Development — Nektar Therapeutics
Nektar has crossed the chasm from a drug-delivery-technology company to a product-development company. Dr. Huh describes how they made the transition, and what to look for from them in the future.
Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Thursday, June 08, 2006
Ohio - An Emerging Biotech Region
Date: 04/10/06
Length: 00:05:46
Size: 2.7MB
Thought Leader: Bob Taft, Governor — State of Ohio
When listing the top biotech regions in the U.S., Ohio is not always included with renown biotech states such as California, Massachusetts, or even Wisconsin. Governor Taft explains how Ohio is becoming a top biotech region...
Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Length: 00:05:46
Size: 2.7MB
Thought Leader: Bob Taft, Governor — State of Ohio
When listing the top biotech regions in the U.S., Ohio is not always included with renown biotech states such as California, Massachusetts, or even Wisconsin. Governor Taft explains how Ohio is becoming a top biotech region...
Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Subscribe to:
Posts (Atom)